FIRST INTERSTATE (FIBK) 144/A: 20,000-share sale via Goldman Sachs
Rhea-AI Filing Summary
Notice of proposed sale of 20,000 common shares by a related person through Goldman Sachs. The filer intends to sell $636,800 worth of Common stock (20,000 shares) on 10/07/2025 on the NASD. The filer reports 104,509,863 shares outstanding for the issuer. The 20,000 shares were acquired as a gift on 06/20/2020 from a "Scott Family Member," with the donor's acquisition date listed as 11/03/1993. No securities of the issuer were sold by the filer in the past three months. The notice includes the required certification that the seller is not aware of undisclosed material adverse information.
Positive
- Full Rule 144 fields provided: acquisition date, donor date, broker, and shares outstanding are disclosed
- No sales in prior three months: filer reports "Nothing to Report" for recent dispositions
Negative
- Material information reliance: seller's representation they know no undisclosed material adverse information is a self-certification rather than independent verification
- Limited context on beneficial owner: filer identity and relationship specifics are not detailed in the notice
Insights
Sale appears procedural and Rule 144-compliant on its face.
The notice documents a proposed sale of $636,800 (20,000 common shares) through Goldman Sachs on 10/07/2025, and records the acquisition as a gift on 06/20/2020. Key compliance items—acquisition nature, donor acquisition date, broker identity, and shares outstanding—are provided, which are typical for a Rule 144 filing.
Risks center on accurate disclosure of any material nonpublic information and aggregation rules for related sellers; the signer certifies absence of undisclosed material adverse information. Monitor for any subsequent amendments, actual trade execution records, or additional filings within the pre- and post-sale window.
Transaction size is immaterial to total float but taxable and market-impact considerations remain.
At 20,000 shares versus 104,509,863 shares outstanding, the proposed sale represents a small fraction of outstanding stock (traceable from provided counts). Execution through a major broker may minimize market impact for that volume. The aggregate market value is listed as $636,800, which will be relevant for tax and reporting purposes for the seller.
Investors may note timing (10/07/2025) and that no related sales occurred in the prior three months; watch for a Form 4 or amendment confirming executed disposition and any insider aggregation statements within the statutory window.